Molly Doyle and Eric Lindsey join Commonwealth Health Advisors

Commonwealth Health Advisors is delighted to announce the addition of two new partners to our firm – Molly Doyle and Eric Lindsey

With over 20 years’ experience in Population Health, Service Delivery and Digital Health, Molly has been a Product leader at Pfizer Health Solutions, Health Dialog, Welltok (Predilytics) and meQuilibrium. She has built an impressive track record of bringing new products to market through deep market research, collaborative design and development, and rapid testing and validation to create outstanding user experiences and value for customers. A veteran of 5 start-ups, Molly is known as a big picture thinker with rigorous execution skills who helps organizations mature and scale to drive long-term growth and profitability.

Eric is an executive and entrepreneur with a track record of delivering high levels of revenue in healthcare technology and pharmaceutical services. His extensive commercial leadership experience runs the gamut from small organizations and provider practices to pharmaceutical firms like Pfizer, Sanofi, and Novartis. As an executive with a growth focus, he has built and led commercial organizations for public and private companies including Stryker, IQVIA, and Patient Point. With a successful exit under his belt, Eric is also an investor and entrepreneur who advises many emerging companies with sales planning and execution.

We are exceptionally lucky to have both Molly and Eric join our team, bringing their considerable talents and experience to bear on behalf of our clients.